Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Aura Biosciences, Inc. (AURA) had Cash Flow from Financial Activities of $70.03M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-27.02M |
|
-- |
|
-- |
|
$28.61M |
|
$-28.61M |
|
$1.64M |
|
$-26.97M |
|
$-26.97M |
|
$-27.02M |
|
$-27.02M |
|
$-27.02M |
|
$-27.02M |
|
$-28.61M |
|
$-28.33M |
|
58.02M |
|
58.02M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$183.96M |
|
$2.86M |
|
$20.44M |
|
$204.40M |
|
$14.85M |
|
-- |
|
$14.92M |
|
$29.77M |
|
$174.63M |
|
$174.63M |
|
$174.63M |
|
62.07M |
|
| Cash Flow Statement Financials | |
$-44.13M |
|
$49.79M |
|
|
Cash Flow from Financial Activities |
$70.03M |
$32.46M |
|
$108.14M |
|
$75.69M |
|
$7.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.47% |
|
-15.47% |
|
-13.22% |
|
-15.47% |
|
$2.81 |
|
$-0.76 |
|
$-0.76 |
|